Table 3.
Characteristics of Nocardia infection developed in rheumatic disease patients.
| Case no. | Nocardia spp | Pulmonary nocardiosis | Extrapulmonary lesion | Initial therapy | Outcome |
|---|---|---|---|---|---|
| 1 | N. asteroides | Yes | Mediastinal abscess | IMP/CS + MINO + TMP-SMZ | Remission |
| 2 | N.D. | Yes | Brain abscess | PAPM/BP + CLDM + TMP-SMZ | Remission |
| 3 | N. farcinica | Yes | Iliopsoas abscess | MEPM | Remission |
| 4 | N. nova | Yes | Brain abscess | MEPM + TMP-SMZ | Remission |
| 5 | N. farcinica | Yes | No | MEPM + ABK | Remission |
| 6 | N. farcinica | Yes | No | MEPM | Recurrence |
| 7 | N.D. | Yes | Brain abscess | IMP/CS | Remission |
| 8 | N.D. | Yes | No | TMP-SMZ | Remission |
| 9 | N. farcinica | Yes | No | MEPM | Remission |
| 10 | N. farcinica | Yes | Subcutaneous abscess | TMP-SMZ | Remission |
N.D.: not determined; IMP/CS: imipenem/cilastatin sodium; MINO: minomycin; TMP-SMZ: Trimethoprim-sulfamethoxazole.
PAPM/BP: panipenem-betamipron; CLDM: clindamycin; MEPM: meropenem; ABK: arbekacin.